- Home
- Medical
- Toxicology
- Introduction To Immunotoxicology
Introduction To Immunotoxicology
List Price:
$87.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Jacques Descotes
Format:
Paperback
Pages:
196
Publisher:
CRC Press (December 9, 1998)
Language:
English
Audience:
College/higher education
ISBN-13:
9780748403073
ISBN-10:
0748403078
Weight:
13.625oz
Dimensions:
7" x 10"
File:
TAYLORFRANCIS-TayFran_260513043736269-20260513.xml
Folder:
TAYLORFRANCIS
List Price:
$87.99
Country of Origin:
United States
Case Pack:
36
As low as:
$83.59
Publisher Identifier:
P-CRC
Discount Code:
H
Pub Discount:
30
Imprint:
CRC Press
Overview
This text provides a concise and comprehensive introduction to key immunotoxicological issues. Part One explores the health consequences of immunotoxicity, namely the adverse effects related to chemically-induced immunosuppression and immunostimulation, hypersensitivity reactions and autoimmune diseases, with an overview of major immunotoxicants. Part Two covers the latest methods used to detect and evaluate the unexpected immunotoxic effects of xenobiotics, trends in implementing strategies, and recent changes to the regulatory aspects. Part Three examines possible future developments, including In Vitro methods, biomarkers of immunotixicity and risk assessment.
